This article was originally published in The Gray Sheet
Receives expedited trial date of Nov. 8 for patent infringement and trade secret proceedings against Bedford, Massachusetts firm Cynosure and Cynosure President Horace Furumoto. The dispute involves Cynosure's PhotoGenica V dermatology laser system ("The Gray Sheet" Nov. 9, 1992, I&W-13). Candela says that "in view of the expedited trial schedule, Candela has voluntarily withdrawn its preliminary injunction motion against Cynosure and Furumoto," who was a co-founder of Candela. Furomoto served as its president and CEO until April 1991 ("The Gray Sheet" April 22, 1991, In Brief) and resigned as chairman soon after.
You may also be interested in...
A recent Department of Health and Human Services proposal to review regulations every 10 years may mean good things for the device industry, said David Hoffmeister, partner, Wilson Sonsini Goodrich & Rosati.
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.